A 16-year-old patient with Becker muscular dystrophy is experiencing increased fatigue, shortness of breath, and decreased lung function. The healthcare team is considering the use of nocturnal non-invasive ventilation (NIV) to support his breathing during sleep. Which of the following nursing interventions is most appropriate to implement first when initiating NIV for this patient?

C) Perform a respiratory assessment to establish a baseline before starting NIV.

A) Educate the patient and family about the purpose and benefits of NIV.

B) Assess the patient's understanding of the use and maintenance of the NIV equipment.

C) Perform a respiratory assessment to establish a baseline before starting NIV.

D) Schedule a follow-up appointment with the respiratory therapist post-NIV initiation.

A patient with Becker muscular dystrophy presents with increased fatigue, shortness of breath, and decreased forced vital capacity. Which nursing intervention is most appropriate to address the patient's current respiratory needs?

B) Arrange for a consultation with a respiratory therapist to discuss nocturnal non-invasive ventilation.

A) Encourage the patient to participate in daily strenuous exercises to improve lung capacity.

B) Arrange for a consultation with a respiratory therapist to discuss nocturnal non-invasive ventilation.

C) Instruct the patient to increase fluid intake to thin secretions and ease breathing.

D) Advise the patient to use a rescue inhaler before engaging in physical activities.

A nurse is caring for a patient with worsening heart failure and fluid overload, as indicated by bilateral pitting edema, elevated BNP levels, and mild hyponatremia. Which nursing intervention is most appropriate to prioritize based on the current clinical findings?

A) Administer prescribed diuretics and monitor for electrolyte imbalances.

B) Encourage the patient to increase oral fluid intake to prevent dehydration.

C) Instruct the patient to perform daily vigorous exercises to improve circulation.

D) Advise the patient to consume a high-protein diet to manage swelling.

A nurse is reviewing the care plan for a patient with worsening heart failure, noted by increased bilateral pitting edema and an elevated BNP level. Which intervention should the nurse prioritize to address the patient's fluid overload?

B) Administer prescribed diuretics and monitor electrolyte levels closely.

A) Encourage increased fluid intake to flush out excess sodium.

B) Administer prescribed diuretics and monitor electrolyte levels closely.

C) Suggest the patient lie flat to promote venous return.

D) Advise the patient to increase their sodium intake to balance electrolytes.

A patient with worsening heart failure symptoms is on a low-dose diuretic. Which nursing intervention is most appropriate to address his current symptoms of fatigue, shortness of breath, and paroxysmal nocturnal dyspnea?

A) Educate the patient on the importance of fluid restriction and monitor daily weights.

B) Increase the dose of diuretics to further reduce fluid overload.

C) Encourage the patient to engage in regular exercise to improve cardiac function.

D) Administer supplemental oxygen to maintain oxygen saturation levels above 95%.

A patient with heart failure is experiencing increased fatigue, shortness of breath at rest, and paroxysmal nocturnal dyspnea despite being on a low-dose diuretic. The healthcare team notes a decrease in ejection fraction and the presence of mild jugular venous distention. Which nursing intervention is most appropriate to address the patient's current symptoms and improve his condition?

C) Suggest the addition of an ACE inhibitor to enhance cardiac function.

A) Recommend increasing the dose of his diuretic to reduce fluid overload.

B) Educate the patient on reducing sodium intake to manage fluid retention.

C) Suggest the addition of an ACE inhibitor to enhance cardiac function.

D) Advise the patient to engage in moderate exercise to improve cardiovascular health.

A patient with muscular dystrophy and heart failure is experiencing a persistent dry cough after starting an ACE inhibitor. The healthcare team is considering switching to a different medication. Which medication change could potentially alleviate the cough and minimize renal impact, while still providing effective heart failure management?

B) Switch to an angiotensin II receptor blocker (ARB)

C) Increase the dosage of the ACE inhibitor

D) Switch to a calcium channel blocker

A 17-year-old male with muscular dystrophy and heart failure has been experiencing a persistent dry cough after starting an ACE inhibitor. His mother reports fatigue and breathing difficulties at night, and recent lab results show mild hypokalemia and elevated serum creatinine. Which nursing intervention is the most appropriate to address the patient's current condition?

B) Recommend switching to an ARB to alleviate the cough while monitoring renal function.

A) Educate the patient and family on the importance of increasing fluid intake to manage the cough.

B) Recommend switching to an ARB to alleviate the cough while monitoring renal function.

C) Increase the diuretic dosage to manage fluid retention and reduce dyspnea.

D) Advise the patient to take the ACE inhibitor at bedtime to minimize daytime side effects.

A patient with muscular dystrophy and recently switched from an ACE inhibitor to an ARB is experiencing worsening nighttime breathing difficulties and decreased oxygen saturation. What is the most appropriate initial nursing intervention to address the patient's respiratory status?

B) Elevate the head of the bed to a semi-Fowler's position

A) Encourage the patient to increase daily fluid intake

B) Elevate the head of the bed to a semi-Fowler's position

C) Administer prescribed diuretics to reduce fluid overload

D) Educate the patient on pursed-lip breathing techniques

A patient with muscular dystrophy has recently been switched from an ACE inhibitor to an ARB due to a persistent cough. Despite this change, the patient now presents with increased nighttime breathing difficulties and an oxygen saturation of 89% on room air. Given these findings, which nursing intervention is the priority to address the patient's respiratory status?

A) Encourage deep breathing exercises and monitor oxygen saturation closely.

B) Increase the patient's dietary potassium intake to prevent hypokalemia.

C) Advise the patient to elevate the head of the bed to improve breathing during sleep.

D) Request an immediate cardiology consultation to adjust heart failure medications.

MUScular dystroph - Nursing Case Study

Pathophysiology

• Primary mechanism: Muscular dystrophy primarily involves genetic mutations that affect the production of dystrophin, a critical protein for muscle fiber stability and integrity. The absence or malfunction of dystrophin leads to the gradual degeneration of muscle cells.

• Secondary mechanism: The defective muscle cell membrane allows the influx of calcium ions, which activates enzymes that degrade muscle proteins. This process contributes to increased muscle damage and inflammation, further worsening muscle weakness over time.

• Key complication: Progressive muscle weakness leads to impaired mobility, respiratory issues due to weakened diaphragm muscles, and potential cardiac complications, emphasizing the need for regular monitoring and supportive care in affected individuals.

Patient Profile

Demographics:

18-year-old male, high school student

History:

• Key past medical history: Diagnosed with Becker muscular dystrophy at age 12

• Current medications: Prednisone 10 mg daily, Lisinopril 5 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing difficulty in climbing stairs and rising from seated positions

• Key symptoms: Progressive muscle weakness, frequent falls, mild shortness of breath on exertion

• Vital signs: Blood pressure 140/90 mmHg, heart rate 102 bpm, respiratory rate 20 breaths per minute, temperature 98.6°F

Section 1

New Complications:

In recent weeks, the patient has begun experiencing increased fatigue and more frequent episodes of shortness of breath, particularly during routine activities such as walking between classes or participating in mild physical activity. His mother has also noticed that he seems more lethargic in the evenings and has been requiring longer periods of rest. During a follow-up visit, the healthcare team noted that his lung function tests revealed a decreased forced vital capacity (FVC) of 60% predicted, indicating a decline in respiratory function. Additionally, echocardiogram results showed mild left ventricular dysfunction, with an ejection fraction of 45%, suggesting the early onset of cardiomyopathy, a common complication in Becker muscular dystrophy.

These findings have prompted a reassessment of his management plan. The team has decided to increase the frequency of his cardiology and pulmonology evaluations and has arranged for a consultation with a respiratory therapist to discuss potential interventions such as nocturnal non-invasive ventilation to support his breathing during sleep. Additionally, the team is considering the introduction of an ACE inhibitor or a beta-blocker to address his cardiac function, given the evidence of left ventricular compromise. This change in clinical status underscores the importance of a multidisciplinary approach in managing Becker muscular dystrophy, focusing on proactive monitoring and timely interventions to mitigate the progression of complications.

The healthcare team will continue to closely monitor the patient’s response to these interventions and adjust the treatment plan as needed, emphasizing the importance of maintaining his quality of life while managing the chronic nature of his condition. The patient and his family are encouraged to engage in regular communication with his healthcare providers to address any emerging symptoms or concerns promptly.

Section 2

During a routine follow-up visit, the patient’s mother reports that he has been experiencing increased difficulty in performing daily activities and has noticed swelling in his lower extremities, particularly around the ankles. This prompts the healthcare team to perform a thorough assessment, revealing a blood pressure of 135/85 mmHg, elevated from previous visits, and a heart rate of 95 beats per minute. His oxygen saturation levels are slightly decreased at 92% on room air, down from his usual baseline of 95%. Physical examination confirms the presence of bilateral pitting edema in the lower legs, raising concerns about worsening cardiac function and fluid retention.

In light of these findings, the team orders additional diagnostic tests, including serum electrolytes, a complete blood count, and a B-type natriuretic peptide (BNP) test to evaluate heart failure status. The laboratory results reveal a BNP level of 480 pg/mL, significantly elevated from prior levels, indicating increased cardiac stress and potential exacerbation of heart failure. Electrolyte panels show mild hyponatremia, which is consistent with fluid overload. These results support the hypothesis that the patient's left ventricular dysfunction is progressing, necessitating an adjustment in his cardiac medication regimen.

The healthcare team discusses the situation with the patient and his family, emphasizing the need for close monitoring and possible initiation of diuretics to manage fluid overload. They review the importance of adhering to a low-sodium diet and monitoring daily weights to detect fluid changes early. The team also reiterates the importance of timely interventions and regular follow-up appointments to prevent further complications, highlighting the role of the patient and family in managing his condition and maintaining communication with healthcare providers.

Section 3

In the following weeks, the patient begins treatment with a low-dose diuretic to address the fluid overload and swelling in his lower extremities. Initially, the patient and his family notice a reduction in the edema, and his weight stabilizes, suggesting that the intervention is effectively managing the fluid retention. However, during a subsequent follow-up visit, the patient presents with new symptoms that warrant further investigation. His mother reports that he has been experiencing increased fatigue and occasional shortness of breath, even at rest. Additionally, he has been waking up at night due to difficulty breathing, a condition known as paroxysmal nocturnal dyspnea.

The healthcare team performs a thorough reassessment, noting that his blood pressure is now 140/90 mmHg, and his heart rate has increased to 100 beats per minute. Oxygen saturation remains at 92% on room air, which is concerning given his previous baseline. Physical examination reveals persistent bilateral pitting edema, and the presence of mild jugular venous distention, suggesting possible right-sided heart strain. These findings, combined with his symptoms, raise concerns about the progression of heart failure despite the current treatment regimen.

Given these developments, the healthcare team decides to conduct further diagnostic testing, including an echocardiogram to assess cardiac function more precisely. The echocardiogram reveals a decrease in ejection fraction from previous measurements, indicating worsening left ventricular systolic function. This confirms the need for an adjustment in his cardiac management plan, possibly incorporating additional medication such as ACE inhibitors or beta-blockers to improve cardiac output and reduce symptoms. The healthcare team discusses these findings and potential treatment modifications with the patient and his family, emphasizing the importance of continued adherence to dietary and lifestyle recommendations and the need for close monitoring and follow-up care to mitigate the risk of further complications.

Section 4

In the following two weeks after adjusting the patient's cardiac management plan to include an ACE inhibitor, the healthcare team closely monitors his progress. Despite initial hopes for improvement, the patient returns to the clinic with his mother, who reports that he has developed a persistent dry cough, a known side effect of the new medication. Moreover, the patient continues to experience fatigue and nighttime breathing difficulties, although the frequency of paroxysmal nocturnal dyspnea episodes has slightly decreased. His blood pressure is now 135/85 mmHg, showing some improvement, but his heart rate remains elevated at 98 beats per minute. Oxygen saturation has dropped slightly to 91% on room air, further raising concerns about his respiratory status.

Laboratory tests reveal a slight elevation in serum creatinine levels, suggesting a potential impact on renal function, possibly due to the ACE inhibitor. Electrolyte analysis shows mild hypokalemia, which could be a consequence of the continued use of the diuretic. These findings prompt the team to consider the balance between managing heart failure symptoms and the side effects of the medications. The decision is made to adjust the diuretic dosage and supplement with potassium to address the electrolyte imbalance. Additionally, the team discusses the possibility of switching to a different class of heart failure medication to mitigate the cough and renal effects while maintaining cardiac support.

The patient and his family are informed of these developments and the rationale behind the medication adjustments. The healthcare team emphasizes the importance of monitoring for any new symptoms and adhering to the revised medication regimen, as well as the dietary and fluid intake recommendations. They schedule a follow-up visit in two weeks to assess the patient's response to these interventions and ensure that his heart failure management remains on track. This ongoing monitoring is crucial to prevent further deterioration and to manage the delicate balance required in treating the complexities of muscular dystrophy with concurrent cardiac involvement.

Section 5

Two weeks later, the patient returns to the clinic for the scheduled follow-up visit. His mother reports that the dry cough has significantly improved since transitioning from the ACE inhibitor to an angiotensin II receptor blocker (ARB), which the healthcare team had implemented to address the side effect while maintaining cardiac support. However, the patient continues to experience fatigue, and his nighttime breathing difficulties have worsened, suggesting the need for further evaluation of his respiratory status. Upon examination, his vital signs reveal a blood pressure of 130/80 mmHg, which is a slight improvement, and a reduced heart rate of 92 beats per minute. His oxygen saturation remains concerning at 89% on room air, indicating a persistent issue with oxygenation.

Laboratory tests conducted during this visit show a further increase in serum creatinine, now at the upper limit of normal, raising concerns about ongoing renal function compromise. The mild hypokalemia previously noted has resolved with potassium supplementation, but new laboratory findings reveal a slight elevation in liver enzymes, which could indicate a developing hepatic issue potentially related to the patient's muscular dystrophy progression or the new medication regimen. Given these findings, the healthcare team decides to conduct additional diagnostic testing, including a chest X-ray and pulmonary function tests, to better understand the patient's respiratory difficulties.

The healthcare team also discusses the importance of continued monitoring and potential adjustments in the patient's treatment plan. They emphasize the need for vigilance in recognizing any new or worsening symptoms and stress the importance of adhering to the prescribed medications and lifestyle recommendations. The decision is made to arrange for a cardiology consultation to explore advanced heart failure management options, given the complexities of managing the patient's condition with concurrent muscular dystrophy. This multidisciplinary approach aims to optimize the patient's quality of life while addressing the evolving challenges of his health status.